Crossref journal-article
Elsevier BV
Neuroscience (78)
Bibliography

Trushina, E., & McMurray, C. T. (2007). Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience, 145(4), 1233–1248.

Authors 2
  1. E. Trushina (first)
  2. C.T. McMurray (additional)
References 173 Referenced 353
  1. 10.1086/303056 / Am J Hum Genet / Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia by Adamec (2000)
  2. 10.1016/j.tibs.2006.01.001 / Trends Biochem Sci / Chelatases: distort to select? by Al-Karadaghi (2006)
  3. 10.1006/nbdi.2001.0406 / Neurobiol Dis / Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington’s disease by Andreassen (2001)
  4. 10.1002/ana.410430321 / Ann Neurol / Complex I defect in muscle from patients with Huntington’s disease by Arenas (1998)
  5. 10.1016/j.neuron.2005.06.005 / Neuron / p53 Mediates cellular dysfunction and behavioral abnormalities in Huntington’s disease by Bae (2005)
  6. 10.1002/ana.410310202 / Ann Neurol / Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? by Beal (1992)
  7. 10.1002/ana.20624 / Ann Neurol / Mitochondria take center stage in aging and neurodegeneration by Beal (2005)
  8. 10.1523/JNEUROSCI.11-06-01649.1991 / J Neurosci / Chronic quinolinic acid lesions in rats closely resemble Huntington’s disease by Beal (1991)
  9. 10.1091/mbc.E05-07-0607 / Mol Biol Cell / Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin by Benchoua (2006)
  10. 10.1016/j.bbrc.2004.08.035 / Biochem Biophys Res Commun / Deranged neuronal calcium signaling and Huntington disease by Bezprozvanny (2004)
  11. 10.1016/j.mrfmmm.2003.07.002 / Mutat Res / Mutagenicity, toxicity and repair of DNA base damage induced by oxidation by Bjelland (2003)
  12. 10.1042/bst0250944 / Biochem Soc Trans / Potential mechanisms for nitric oxide-mediated impairment of brain mitochondrial energy metabolism by Bolanos (1997)
  13. {'key': '10.1016/j.neuroscience.2006.10.056_bib13', 'first-page': '137', 'article-title': 'Nucleotide excision repair syndromes: xeroderma pigmentosum, cockayne syndrome, and trichothiodystrophy', 'volume': 'Vol. 3', 'author': 'Bootsma', 'year': '2005'} / Nucleotide excision repair syndromes: xeroderma pigmentosum, cockayne syndrome, and trichothiodystrophy by Bootsma (2005)
  14. 10.1172/JCI27607 / J Clin Invest / Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase by Borrell-Pages (2006)
  15. 10.1006/bbrc.1996.0441 / Biochem Biophys Res Commun / Diethyldithiocarbamate treatment up regulates manganese superoxide dismutase gene expression in rat liver by Borrello (1996)
  16. 10.1016/0014-5793(92)81342-J / FEBS Lett / Manganese deficiency and transcriptional regulation of mitochondrial superoxide dismutase in hepatomas by Borrello (1992)
  17. 10.1023/B:NERE.0000014824.04728.dd / Neurochem Res / The energetics of Huntington’s disease by Browne (2004)
  18. 10.1002/ana.410410514 / Ann Neurol / Oxidative damage and metabolic dysfunction in Huntington’s disease: selective vulnerability of the basal ganglia by Browne (1997)
  19. 10.1111/j.1471-4159.2005.03036.x / J Neurochem / Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington’s disease by Brustovetsky (2005)
  20. 10.1126/science.1098991 / Science / Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity by Bulteau (2004)
  21. 10.1126/science.271.5254.1423 / Science / Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion by Campuzano (1996)
  22. 10.1016/j.neurobiolaging.2004.11.008 / Neurobiol Aging / Somatic mitochondrial DNA mutations in single neurons and glia by Cantuti-Castelvetri (2005)
  23. 10.1016/S0021-9258(18)43894-X / J Biol Chem / Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide by Castro (1994)
  24. 10.1016/S0166-2236(00)01721-5 / Trends Neurosci / Loss of normal huntingtin function: new developments in Huntington’s disease research by Cattaneo (2001)
  25. 10.1093/hmg/11.3.217 / Hum Mol Genet / Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia by Cavadini (2002)
  26. 10.1016/j.nbd.2005.12.007 / Neurobiol Dis / Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons by Chang (2006)
  27. 10.1093/hmg/10.19.2061 / Hum Mol Genet / Disabled early recruitment of antioxidant defenses in Friedreich’s ataxia by Chantrel-Groussard (2001)
  28. 10.1093/hmg/ddh162 / Hum Mol Genet / Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release by Choo (2004)
  29. 10.1038/sj.cdd.4401967 / Cell Death Differ / Increased apoptosis, huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington’s disease subjects by Ciammola (2006)
  30. 10.1038/nrc1652 / Nat Rev Cancer / Cancer in xeroderma pigmentosum and related disorders of DNA repair by Cleaver (2005)
  31. 10.1016/S0306-4522(01)00409-2 / Neuroscience / Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington’s disease by Clifford (2002)
  32. 10.1074/jbc.M108414200 / J Biol Chem / Lipid droplet binding and oligomerization properties of the Parkinson’s disease protein alpha-synuclein by Cole (2002)
  33. 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U / Ann Neurol / Friedreich’s ataxia: point mutations and clinical presentation of compound heterozygotes by Cossee (1999)
  34. 10.1016/0304-4157(85)90002-4 / Biochim Biophys Acta / Lipids of mitochondria by Daum (1985)
  35. 10.1016/j.dnarep.2004.05.005 / DNA Repair (Amst) / Mechanisms of DNA damage recognition and strand discrimination in human nucleotide excision repair by Dip (2004)
  36. 10.1126/science.1072613 / Science / Sp1 and TAFII130 transcriptional activity disrupted in early Huntington’s disease by Dunah (2002)
  37. 10.1093/mutage/gel024 / Mutagenesis / TDP1-dependent DNA single-strand break repair and neurodegeneration by El-Khamisy (2006)
  38. 10.1212/WNL.55.11.1752 / Neurology / Increased levels of plasma malondialdehyde in Friedreich ataxia by Emond (2000)
  39. 10.1093/hmg/6.13.2205 / Hum Mol Genet / Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin by Engelender (1997)
  40. 10.1016/S0891-5849(00)00161-1 / Free Radic Biol Med / Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene by Esposito (2000)
  41. 10.1038/sj.onc.1209021 / Oncogene / p53 Tumor suppressor protein regulates the levels of huntingtin gene expression by Feng (2006)
  42. 10.1523/JNEUROSCI.22-05-01592.2002 / J Neurosci / Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington’s disease by Ferrante (2002)
  43. 10.1523/JNEUROSCI.20-12-04389.2000 / J Neurosci / Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease by Ferrante (2000)
  44. 10.1016/0003-2697(90)90544-J / Anal Biochem / Conditions influencing yield and analysis of 8-hydroxy-2′-deoxyguanosine in oxidatively damaged DNA by Floyd (1990)
  45. 10.1038/nature01408 / Nature / DNA damage and repair by Friedberg (2003)
  46. 10.1016/S1097-2765(00)80058-1 / Mol Cell / GAA instability in Friedreich’s ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases by Gacy (1998)
  47. 10.1093/hmg/ddi461 / Hum Mol Genet / Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity by Gakh (2006)
  48. 10.1016/S0021-9258(18)52319-X / J Biol Chem / Superoxide sensitivity of the Escherichia coli 6-phosphogluconate dehydratase by Gardner (1991)
  49. 10.1074/jbc.270.22.13399 / J Biol Chem / Superoxide radical and iron modulate aconitase activity in mammalian cells by Gardner (1995)
  50. 10.1038/nrg1691 / Nat Rev Genet / Diseases of unstable repeat expansion: mechanisms and common principles by Gatchel (2005)
  51. 10.1016/j.cell.2004.06.018 / Cell / Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules by Gauthier (2004)
  52. 10.1093/hmg/ddg046 / Hum Mol Genet / Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington’s disease knock-in mice by Gines (2003)
  53. 10.1002/ana.20754 / Ann Neurol / Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice by Gizatullina (2006)
  54. 10.1016/j.bbrc.2006.01.136 / Biochem Biophys Res Commun / Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction by Goswami (2006)
  55. 10.1016/j.cell.2006.04.026 / Cell / Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin by Graham (2006)
  56. 10.1002/ana.410390317 / Ann Neurol / Mitochondrial defect in Huntington’s disease caudate nucleus by Gu (1996)
  57. 10.1006/exnr.2000.7626 / Exp Neurol / Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production by Guidetti (2001)
  58. 10.1016/S0021-9258(19)74369-5 / J Biol Chem / Absence of electron transport (Rho 0 state) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia by Guidot (1993)
  59. 10.1016/S0896-6273(03)00594-4 / Neuron / Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila by Gunawardena (2003)
  60. 10.1016/j.mrrev.2003.06.002 / Mutat Res / Functional characterization of global genomic DNA repair and its implications for cancer by Hanawalt (2003)
  61. 10.1042/CS20050148 / Clin Sci (Lond) / Pharmaceutical, cellular and genetic therapies for Huntington’s disease by Handley (2006)
  62. 10.1016/S0968-0004(03)00168-3 / Trends Biochem Sci / The hunt for huntingtin function: interaction partners tell many different stories by Harjes (2003)
  63. 10.1093/geronj/11.3.298 / J Gerontol / Aging: a theory based on free radical and radiation chemistry by Harman (1956)
  64. 10.1016/S0079-6603(01)68100-5 / Prog Nucleic Acid Res Mol Biol / Multiple DNA glycosylases for repair of 8-oxoguanine and their potential in vivo functions by Hazra (2001)
  65. 10.1212/01.wnl.0000194318.74946.b6 / Neurology / Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG by Hersch (2006)
  66. 10.1093/hmg/9.19.2789 / Hum Mol Genet / Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles by Hilditch-Maguire (2000)
  67. 10.1016/0304-4157(92)90035-9 / Biochim Biophys Acta / Cardiolipins and biomembrane function by Hoch (1992)
  68. 10.1212/WNL.45.10.1879 / Neurology / Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington’s disease patients by Horton (1995)
  69. 10.1111/j.1471-4159.2006.03733.x / J Neurochem / Neuronal cell death caused by inhibition of intracellular cholesterol trafficking is caspase dependent and associated with activation of the mitochondrial apoptosis pathway by Huang (2006)
  70. 10.3109/10715769309145868 / Free Radic Res Commun / The reaction of no with superoxide by Huie (1993)
  71. {'key': '10.1016/j.neuroscience.2006.10.056_bib71', 'first-page': '129', 'article-title': 'The role of mitochondrial DNA in Huntington’s disease', 'volume': '1', 'author': 'Irwin', 'year': '1989', 'journal-title': 'J Mol Neurosci'} / J Mol Neurosci / The role of mitochondrial DNA in Huntington’s disease by Irwin (1989)
  72. 10.1212/WNL.50.5.1357 / Neurology / 1H NMR spectroscopy studies of Huntington’s disease: correlations with CAG repeat numbers by Jenkins (1998)
  73. 10.1111/j.1432-1033.2004.04250.x / Eur J Biochem / alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis by Jo (2004)
  74. 10.1093/hmg/11.11.1351 / Hum Mol Genet / The mitochondrial protein frataxin prevents nuclear damage by Karthikeyan (2002)
  75. 10.1093/hmg/ddg349 / Hum Mol Genet / Reduction in frataxin causes progressive accumulation of mitochondrial damage by Karthikeyan (2003)
  76. 10.1523/JNEUROSCI.20-19-07268.2000 / J Neurosci / Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy by Kegel (2000)
  77. 10.1074/jbc.M103946200 / J Biol Chem / Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription by Kegel (2002)
  78. 10.1074/jbc.M503672200 / J Biol Chem / Huntingtin associates with acidic phospholipids at the plasma membrane by Kegel (2005)
  79. 10.1073/pnas.93.24.13635 / Proc Natl Acad Sci U S A / Superoxide accelerates DNA damage by elevating free-iron levels by Keyer (1996)
  80. 10.1126/science.2814477 / Science / Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation by King (1989)
  81. 10.1002/ana.410410206 / Ann Neurol / Energy metabolism defects in Huntington’s disease and effects of coenzyme Q10 by Koroshetz (1997)
  82. 10.1016/S0021-9258(18)61255-4 / J Biol Chem / alpha, beta-Dihydroxyisovalerate dehydratase by Kuo (1987)
  83. 10.1016/S0896-6273(04)00017-0 / Neuron / Cell cycle activation linked to neuronal cell death initiated by DNA damage by Kruman (2004)
  84. 10.1086/318207 / Am J Hum Genet / Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo by Leavitt (2001)
  85. 10.1111/j.1471-4159.2005.03605.x / J Neurochem / Wild-type huntingtin protects neurons from excitotoxicity by Leavitt (2006)
  86. 10.1016/j.mad.2006.01.022 / Mech Ageing Dev / Aging and neurodegeneration by Lee (2006)
  87. 10.1128/MCB.22.5.1277-1287.2002 / Mol Cell Biol / Interaction of Huntington disease protein with transcriptional activator Sp1 by Li (2002)
  88. 10.1523/JNEUROSCI.18-04-01261.1998 / J Neurosci / Interaction of huntingtin-associated protein with dynactin P150Glued by Li (1998)
  89. 10.1016/j.tig.2004.01.008 / Trends Genet / Huntingtin-protein interactions and the pathogenesis of Huntington’s disease by Li (2004)
  90. 10.1016/j.tibs.2005.01.006 / Trends Biochem Sci / Iron-sulfur-protein biogenesis in eukaryotes by Lill (2005)
  91. 10.1073/pnas.96.20.11492 / Proc Natl Acad Sci U S A / Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia by Lodi (1999)
  92. 10.1002/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I / Ann Neurol / Abnormal in vivo skeletal muscle energy metabolism in Huntington’s disease and dentatorubropallidoluysian atrophy by Lodi (2000)
  93. 10.1089/ars.2006.8.438 / Antioxid Redox Signal / Friedreich’s ataxia: From disease mechanisms to therapeutic interventions by Lodi (2006)
  94. 10.1021/bi971894b / Biochemistry / Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues by MacMillan-Crow (1998)
  95. 10.1016/j.nbd.2005.11.003 / Neurobiol Dis / Induction of apoptosis in cells expressing exogenous Hippi, a molecular partner of huntingtin-interacting protein Hip1 by Majumder (2006)
  96. 10.1016/0140-6736(90)92242-A / Lancet / Mitochondrial function and parental sex effect in Huntington’s disease by Mann (1990)
  97. 10.1074/jbc.273.21.13245 / J Biol Chem / Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1 by Manna (1998)
  98. 10.1111/j.1460-9568.2006.04686.x / Eur J Neurosci / Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington’s disease knock-in striatal cells by Mao (2006)
  99. 10.1016/j.jchromb.2005.04.023 / J Chromatogr B Analyt Technol Biomed Life Sci / Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview by Mariani (2005)
  100. 10.1196/annals.1306.004 / Ann N Y Acad Sci / Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders by Mattson (2004)
  101. 10.1128/JB.180.3.622-625.1998 / J Bacteriol / Endogenous superoxide dismutase levels regulate iron-dependent hydroxyl radical formation in Escherichia coli exposed to hydrogen peroxide by McCormick (1998)
  102. 10.1016/j.mrfmmm.2005.03.006 / Mutant Res / To die or not to die: DNA repair in neurons by McMurray (2005)
  103. 10.1093/hmg/ddg295 / Hum Mol Genet / Pathogenesis of polyglutamine disorders: aggregation revisited by Michalik (2003)
  104. 10.1016/0891-5849(94)90079-5 / Free Radic Biol Med / Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress by Michiels (1994)
  105. 10.1074/jbc.M504749200 / J Biol Chem / Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin by Milakovic (2005)
  106. 10.1093/hmg/6.8.1261 / Hum Mol Genet / The Friedreich ataxia GAA triplet repeat: premutation and normal alleles by Montermini (1997)
  107. 10.1212/WNL.49.2.606 / Neurology / Somatic mosaicism for Friedreich’s ataxia GAA triplet repeat expansions in the central nervous system by Montermini (1997)
  108. 10.1093/hmg/11.17.2025 / Hum Mol Genet / The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins by Muhlenhoff (2002)
  109. 10.1126/science.1056784 / Science / Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity by Nucifora (2001)
  110. 10.1074/jbc.273.23.14588 / J Biol Chem / Inhibitory effects of expanded GAA by Ohshima (1998)
  111. 10.1016/0006-291X(92)91845-H / Biochem Biophys Res Commun / Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells by Ono (1992)
  112. 10.1016/S0003-9861(02)00585-4 / Arch Biochem Biophys / In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington’s disease by Panov (2003)
  113. 10.1038/nn884 / Nat Neurosci / Early mitochondrial calcium defects in Huntington’s disease are a direct effect of polyglutamines by Panov (2002)
  114. 10.1074/jbc.M303158200 / J Biol Chem / Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation by Park (2003)
  115. 10.1016/S0006-8993(00)02082-5 / Brain Res / Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease by Perez-Severiano (2000)
  116. 10.1016/S0968-0004(98)01350-4 / Trends Biochem Sci / Glutamine repeats and neurodegenerative diseases: molecular aspects by Perutz (1999)
  117. 10.1046/j.1365-2362.2001.00922.x / Eur J Clin Invest / Glutathione in blood of patients with Friedreich’s ataxia by Piemonte (2001)
  118. 10.1016/S0304-3940(99)00578-9 / Neurosci Lett / Oxidative damage to mitochondrial DNA in Huntington’s disease parietal cortex by Polidori (1999)
  119. 10.1016/j.etp.2005.05.015 / Exp Toxicol Pathol / Oxidative DNA modifications by Poulsen (2005)
  120. 10.1038/84818 / Nat Genet / Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits by Puccio (2001)
  121. 10.1016/j.bbrc.2006.01.007 / Biochem Biophys Res Commun / Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria by Puranam (2006)
  122. 10.1006/abbi.1994.1013 / Arch Biochem Biophys / Inhibition of mitochondrial electron transport by peroxynitrite by Radi (1994)
  123. 10.1074/jbc.274.8.4497 / J Biol Chem / The yeast frataxin homologue mediates mitochondrial iron efflux by Radisky (1999)
  124. 10.1016/S0092-8674(03)00686-X / Cell / Secrets of a secretase: N-cadherin proteolysis regulates CBP function by Rao (2003)
  125. 10.1074/jbc.272.5.2753 / J Biol Chem / Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways by Read (1997)
  126. 10.1111/j.1471-4159.2005.03530.x / J Neurochem / Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer’s disease by Reddy (2006)
  127. 10.1523/JNEUROSCI.20-10-03705.2000 / J Neurosci / Wild-type huntingtin protects from apoptosis upstream of caspase-3 by Rigamonti (2000)
  128. 10.1038/nm1066 / Nat Med / Protein aggregation and neurodegenerative disease by Ross (2004)
  129. 10.1038/ng1097-215 / Nat Genet / Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia by Rötig (1997)
  130. 10.1093/hmg/ddh082 / Hum Mol Genet / Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway by Ruan (2004)
  131. 10.1002/mds.20373 / Mov Disord / Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington’s disease by Saft (2005)
  132. 10.1074/jbc.M101879200 / J Biol Chem / Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription by Sakamoto (2001)
  133. 10.1007/s001090100223 / J Mol Med / Mechanisms for neuronal cell death and dysfunction in Huntington’s disease: pathological cross-talk between the nucleus and the mitochondria? by Sawa (2001)
  134. 10.1038/13518 / Nat Med / Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization by Sawa (1999)
  135. 10.1093/hmg/ddi319 / Hum Mol Genet / HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism by Seong (2005)
  136. 10.1002/mds.10229 / Mov Disord / Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington’s disease by Schiefer (2002)
  137. 10.1016/S0304-3940(01)02326-6 / Neurosci Lett / Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington’s disease transgenic mouse model by Schilling (2001)
  138. 10.1212/WNL.55.11.1719 / Neurology / Oxidative stress in patients with Friedreich ataxia by Schulz (2000)
  139. 10.1023/A:1006904904514 / Mol Cell Biochem / The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappaB by Shi (1999)
  140. 10.1046/j.1440-1789.2000.00350.x / Neuropathology / Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases by Shimohata (2000)
  141. 10.1093/hmg/11.7.815 / Hum Mol Genet / Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro by Shoichet (2002)
  142. 10.1196/annals.1354.022 / Ann N Y Acad Sci / Mitochondria damage checkpoint, aging, and cancer by Singh (2006)
  143. 10.1016/j.mad.2005.09.020 / Mech Ageing Dev / Cholesterol and Alzheimer’s disease: is there a relation? by Sjogren (2006)
  144. 10.1016/j.mad.2005.09.010 / Mech Ageing Dev / Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation by Squitieri (2006)
  145. 10.1073/pnas.100110097 / Proc Natl Acad Sci U S A / The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription by Steffan (2000)
  146. 10.1074/jbc.M310226200 / J Biol Chem / Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington’s disease that contributes to polyglutamine pathogenesis by Sugars (2004)
  147. 10.1111/j.1471-4159.2005.03620.x / J Neurochem / Interaction of huntingtin fragments with brain membranes: clues to early dysfunction in Huntington’s disease by Suopanki (2006)
  148. 10.1006/bbrc.1999.1095 / Biochem Biophys Res Commun / Characterization of cybrid cell lines containing mtDNA from Huntington’s disease patients by Swerdlow (1999)
  149. 10.1016/S0896-6273(03)00569-5 / Neuron / Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport by Szebenyi (2003)
  150. 10.1212/01.WNL.0000160388.96242.77 / Neurology / High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study by Tabrizi (2005)
  151. 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E / Ann Neurol / Biochemical abnormalities and excitotoxicity in Huntington’s disease brain by Tabrizi (1999)
  152. 10.1016/0003-9861(87)90624-2 / Arch Biochem Biophys / Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme by Takahashi (1987)
  153. 10.1093/hmg/10.19.2099 / Hum Mol Genet / Frataxin expression rescues mitochondrial dysfunctions in FRDA cells by Tan (2001)
  154. 10.1073/pnas.0409402102 / Proc Natl Acad Sci U S A / Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington’s disease by Tang (2005)
  155. 10.1016/S0896-6273(03)00366-0 / Neuron / Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1 by Tang (2003)
  156. 10.1111/j.1460-9568.2004.03633.x / Eur J Neurosci / HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons by Tang (2004)
  157. 10.1016/0092-8674(93)90585-E / Cell / A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes (1993)
  158. 10.1128/MCB.24.18.8195-8209.2004 / Mol Cell Biol / Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro by Trushina (2004)
  159. 10.1073/pnas.2034961100 / Proc Natl Acad Sci U S A / Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington’s disease by Trushina (2003)
  160. 10.1016/S0169-328X(97)00205-2 / Brain Res Mol Brain Res / Huntington’s disease gene product, huntingtin, associates with microtubules in vitro by Tukamoto (1997)
  161. 10.1523/JNEUROSCI.3355-05.2005 / J Neurosci / Dysfunction of the cholesterol biosynthetic pathway in Huntington’s disease by Valenza (2005)
  162. 10.1111/j.1440-1681.2005.04313.x / Clin Exp Pharmacol Physiol / Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington’s disease by van Dellen (2005)
  163. 10.1073/pnas.83.11.3820 / Proc Natl Acad Sci U S A / A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen by van Loon (1986)
  164. 10.1016/S0021-9258(19)39880-1 / J Biol Chem / Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor by Visner (1990)
  165. 10.1016/S0960-8966(00)00108-5 / Neuromuscul Disord / Mitochondrial impairment of human muscle in Friedreich ataxia in vivo by Vorgerd (2000)
  166. 10.1093/hmg/10.17.1807 / Hum Mol Genet / The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis by Waelter (2001)
  167. 10.1038/ng1297-404 / Nat Genet / Huntingtin is required for neurogenesis and is not impaired by the Huntington’s disease CAG expansion by White (1997)
  168. 10.1016/S0022-510X(02)00432-X / J Neurol Sci / Frataxin and frataxin deficiency in Friedreich’s ataxia by Wilson (2003)
  169. 10.1093/hmg/8.3.425 / Hum Mol Genet / The Friedreich’s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis by Wong (1999)
  170. 10.1093/hmg/10.17.1829 / Hum Mol Genet / Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease by Wyttenbach (2001)
  171. 10.1074/jbc.M412898200 / J Biol Chem / Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function by Yu (2005)
  172. 10.1016/S0896-6273(02)00615-3 / Neuron / Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington’s disease by Zeron (2002)
  173. 10.1177/002215540004800502 / J Histochem Cytochem / Cellular and subcellular localization of catalase in the heart of transgenic mice by Zhou (2000)
Dates
Type When
Created 18 years, 6 months ago (Feb. 15, 2007, 7:04 a.m.)
Deposited 4 years ago (Aug. 8, 2021, 4:18 p.m.)
Indexed 2 days, 14 hours ago (Sept. 2, 2025, 6:39 a.m.)
Issued 18 years, 5 months ago (April 1, 2007)
Published 18 years, 5 months ago (April 1, 2007)
Published Print 18 years, 5 months ago (April 1, 2007)
Funders 0

None

@article{Trushina_2007, title={Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases}, volume={145}, ISSN={0306-4522}, url={http://dx.doi.org/10.1016/j.neuroscience.2006.10.056}, DOI={10.1016/j.neuroscience.2006.10.056}, number={4}, journal={Neuroscience}, publisher={Elsevier BV}, author={Trushina, E. and McMurray, C.T.}, year={2007}, month=apr, pages={1233–1248} }